Senior Vice President and Chief Medical Officer · PALVELLA THERAPEUTICS, INC. (PVLA)

Tim Demuth

FY2021 is the first fiscal year CompBrief holds for Tim Demuth as a named executive officer of PALVELLA THERAPEUTICS; the record below is that year, complete. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2021

$1,246,462

Salary $169,515Stock awards $0

2nd of 3 named executive officers at Palvella Therapeutics by FY2021 total.

3 named officers on file for PALVELLA THERAPEUTICS, FY2021

Tim Demuth’s pay file — $29

  • 1 fiscal year of pay, line by line

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how PALVELLA THERAPEUTICS’s whole pay program stands against its peers

  • PALVELLA THERAPEUTICS’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on PVLA→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed April 29, 2022 (DEF 14A).

Free

Get Tim Demuth’s full pay file as a PDF — free

More than this page: up to 10 years of Tim’s pay history, a side-by-side peer comparison, and a one-page board summary — the whole file, yours now and by email.

Tim Demuth compensation by year

PALVELLA THERAPEUTICS Summary Compensation Table · the one fiscal year held
In US dollars, as PALVELLA THERAPEUTICS reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2021
Salary$169,515
Bonus$0
Stock awards$0
Option awards$851,300
Non-equity incentive$81,200
Pension and deferred compensation$0
All other$144,447
Total$1,246,462

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: PALVELLA THERAPEUTICS, INC. DEF 14A filed April 29, 2022, accession 0001583648-22-000019, and prior-year filings. Open the filing on EDGAR.

How this page was built: the PALVELLA THERAPEUTICS, INC. filed document, accession 0001583648-22-000019. Every figure is read from that document and cited to the page and table it appears in. Filed April 29, 2022.

PALVELLA THERAPEUTICS’s named executive officers, FY2021

as the company reported each
Named executive officerRoleFY2021 total
Stephen YoderChief Executive Officer$1,692,917
Tim Demuth · this pageSenior Vice President and Chief Medical Officer$1,246,462
Hitto KaufmannSenior Vice President and Chief Scientific Officer (9)$876,757

The full PALVELLA THERAPEUTICS compensation record

free company brief

This page is one person within PALVELLA THERAPEUTICS's record. The company brief lists every named executive, each linking to their own page.

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are PALVELLA THERAPEUTICS's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Tim Demuth's compensation dossier · One-time report. No refunds.